Literature DB >> 22579884

Percutaneous cryoablation as a salvage therapy for local recurrence of lung cancer.

Taichiro Goto1, Yotaro Izumi, Seishi Nakatsuka, Hiroaki Nomori.   

Abstract

A 66-year-old male was diagnosed with inoperable non-small cell lung cancer, and underwent chemoradiotherapy, to which he achieved a partial response. During subsequent follow-up, positron emission tomography showed a fluorodeoxyglucose uptake lesion within the primary tumor, without evidence of metastatic foci elsewhere in the body. As local disease progression was most suspected, cryoablation was performed for the lesion with high fluorodeoxyglucose uptake. After treatment, there has been no evidence of recurrence for 12 months. Herein, we present a case of percutaneous cryoablation as a salvage therapy for recurrent lung cancer after chemoradiotherapy.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22579884     DOI: 10.1016/j.athoracsur.2012.01.090

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  Salvage surgery after high-dose radiotherapy.

Authors:  Annemie Van Breussegem; Jeroen M Hendriks; Patrick Lauwers; Paul E Van Schil
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

2.  CT-guided percutaneous cryoablation of central lung tumors.

Authors:  Errol Colak; Servet Tatlı; Paul B Shyn; Kemal Tuncalı; Stuart G Silverman
Journal:  Diagn Interv Radiol       Date:  2014 Jul-Aug       Impact factor: 2.630

3.  Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non-small cell lung cancer.

Authors:  Sushant Kumar Das; Ya-Yong Huang; Bing Li; Xiao Xuan Yu; Ru Hui Xiao; Han Feng Yang
Journal:  Oncol Lett       Date:  2019-11-25       Impact factor: 2.967

4.  Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?

Authors:  Waldemar Schreiner; Wojciech Dudek; Sebastian Lettmaier; Rainer Fietkau; Horia Sirbu
Journal:  J Cardiothorac Surg       Date:  2016-01-19       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.